Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Progression of Alzheimer's


Blog Post Results (1-20 of 358)

FILTER RESULTS

Rescuing the golgi puts brakes on Alzheimer’s progress

Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (A?), overwhelm neurons. An apparent side effect of accumulating A? in neurons is the fragmentation...Show More Summary

Movie Review: Julianne Moore faces an Alzheimer’s diagnosis in the nuanced Still Alice

Though shot in the stolidly inconspicuous style of a low-rated cable drama, Still Alice is rarely anything short of compelling, in part because its sense of progression and scale offers such a distinctively unsentimental take on the terminal-countdown tearjerker. Show More Summary

Aricept Works For Us

Aricept is not a cure for Alzheimer's disease, and it does not stop Alzheimer's. When it works well, it is designed to slow the progression of Alzheimer's and improve behavior. Bob DeMarcoAlzheimer's Reading Room The use of Aricept for Alzheimer's disease is controversial. Show More Summary

Alzheimer's Association - 2025 Alzheimer's National Plan Not Likely to Succeed

"Inadequate funding remains the single most important impediment to progress in achieving the research goal of the Alzheimer's National Plan." By Bob DeMarco Alzheimer's Reading Room The U.S. Government has initiated a major effort to prevent and effectively treat Alzheimer's disease by 2025. Show More Summary

Claiming Confirmation of the Amyloid Hypothesis in Alzheimer's Disease

2 months agoHealth / Aging : Fight Aging

Most of the research community proceeds under the assumption that amyloid, deposits of misfolded proteins that form in tissues, is a causative agent in Alzheimer's disease. Amyloid levels rise with age, probably due to progressive failure of clearance mechanisms. Show More Summary

Marijuana May Be a Treatment for Alzheimer's disease

A new preclinical study indicates that THC, the active ingredient in marijuana, may slow or halt the progression of Alzheimer's disease. Alzheimer's Reading Room THC (Tetrahydrocannabinol) is the active ingrient in marijuana that produces a psychoactive reaction. Show More Summary

Marijuana compound may offer treatment for Alzheimer's disease

Tampa, FL (Aug. 26, 2014) -- Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University...Show More Summary

Creating pomegranate drug to stem Alzheimer's, Parkinson's

Research will look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation and slow down the progression of Alzheimer's disease, scientists report. The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Show More Summary

Most Misdiagnosed Form of Dementia Leaves Patients, Doctors Unprepared

Even though Lewy body dementia is second only to Alzheimer's disease as the most common cause of progressive dementia, affecting 1.3 million Americans, the symptoms of LBD are not well recognized by many physicians, especially primary care physicians and other general practitioners. Show More Summary

Experimental drug compound found to reverse effects of Alzheimer's in mice

5 months agoTechnology / Gadgets : Gizmag

While there has been progress made in the fight against Alzheimer's, our understanding of the dispiriting disease remains somewhat limited, with a definitive cure yet to be found. The latest development comes at the hands of researchers...Show More Summary

Artist's self portraits reflect progression of Alzheimer’s disease

5 months agoOdd : Boing Boing

American artist William Utermohlen (1933-2007) was diagnosed with Alzheimer’s disease in 1995. For the remaining five years of his life, he painted self-portraits which revealed the progression of the disease and its effects, as well as Mr. Utermohlen's heartbreaking, desperate attempts to understand what was happening to him.

Toward an oral therapy for treating Alzheimer's disease: Using a cancer drug

Currently, no cure exists for Alzheimer's disease, the devastating neurological disease affecting more than 5 million Americans. But scientists are now reporting new progress on a set of compounds, initially developed for cancer treatment, that shows promise as a potential oral therapy for Alzheimer's. Their study appears in ACS' Journal of Medicinal Chemistry. read more

Neuroprotective role of immune cell discovered

A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis, can actually protect the brain from traumatic brain injury and may slow the progression of neurodegenerative diseases, according to research. Show More Summary

Should Roche’s Failed Trial Give Hope To Alzheimer’s Patients?

Roche’s Genentech unit just released a mid-stage study of a drug that seeks to slow the progression of Alzheimer’s by blocking the accumulation of a protein called amyloid beta. Like every other medicine that has attempted this approach – which remains the main one being pursued by drug companies to battle Alzheimer’s – the drug [...]

Frontotemporal Dementia: Does your loved one really have this instead of Alzheimer’s?

Frontotemporal dementia (FTD) is a cluster of progressive diseases that affect the regions of the brain that control personality, behavior, language, and decision-making. By Carole B. LarkinAlzheimer's Reading RoomAre you sure its Alzheimer's?...Show More Summary

Roche Reports Mixed Results in Trial of an Alzheimer’s Drug

5 months agoHealth : NYT: Health

While the drug, crenezumab, did not slow progression of the disease over all, at the highest doses it seemed to delay a decline in mental ability in patients with mild Alzheimer’s.

Urgent need for Alzheimer's drug development identified: 99.6 percent of drug attempts fail

Researchers have conducted the first-ever analysis of clinical trials for Alzheimer's disease, revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments.

New Tel Aviv University research links Alzheimer's to brain hyperactivity

Patients with Alzheimer's disease run a high risk of seizures. While the amyloid-beta protein involved in the development and progression of Alzheimer's seems the most likely cause for this neuronal hyperactivity, how and why this elevated activity takes place hasn't yet been explained – until now. read more

Is the Progression of Decline in Alzheimer’s Patients the Reverse of Infant Development?

As my mother continued her decline from Alzheimer’s, it was disconcerting to ride the roller coaster of emotions. Wearing the daughter/caregiver hat I felt powerless to change the progression of her disease. By Elaine C PereiraAlzheimer's Reading Room As an Occupational herapist I believe it is. Show More Summary

My Father's Battle with Alzheimers

His memory loss became apparent first. Like many people experiencing Alzheimer's in its early stages, my father began misplacing important objects and forgetting the names of people. As the disease progressed, his conversational skills...Show More Summary

Copyright © 2011 Regator, LLC